0
PYC Therapeutics Limited Banner Image

PYC Therapeutics Limited

  • Ticker PYC
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
PYC Therapeutics Limited Logo Image
  • 11-50 Employees
  • Based in Nedlands, Australia
PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focusesMore on the development of programs for retinal and central nervous system diseases. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
PYC Therapeutics Limited

Most Recent Annual Report

PYC Therapeutics Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports